Marina Biotech Announces Worldwide Non-Exclusive Licensing Agreement for Nucleic Acid Chemistry to Tekmira Pharmaceuticals
November 29, 2012 08:00 ET
|
Marina Biotech
BOTHELL, WA--(Marketwire - Nov 29, 2012) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading oligonucleotide-based drug discovery and development company, announced today that it has entered into a...
Marina Biotech, Inc. Announces Full Year 2011 Financial Results
October 11, 2012 06:30 ET
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwire - Oct 11, 2012) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading RNAi-based drug discovery and development company, today reported financial results for the fiscal year...
Marina Biotech Provides Update on Company Operations
August 22, 2012 06:30 ET
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwire - Aug 22, 2012) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading nucleic acid-based drug discovery and development company, today provided an update on its operations....
Marina Biotech Announces Worldwide Non-Exclusive Licensing Agreement for Nucleic Acid Chemistry
August 03, 2012 06:30 ET
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwire - Aug 3, 2012) - Marina Biotech, Inc. (OTCQX: MRNA), a leading nucleic acid-based drug discovery and development company, announced today that it has entered into a...
Marina Biotech Ceases Most Day-to-Day Operations
June 01, 2012 06:30 ET
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwire - Jun 1, 2012) - Marina Biotech, Inc. (OTCQX: MRNA), a leading nucleic acid-based drug discovery and development company, today announced that it does not currently have...
Marina Biotech and Girindus Group Announce Strategic Alliance
May 21, 2012 06:30 ET
|
Marina Biotech, Inc.
CINCINNATI, OH and HANNOVER, GERMANY and BOTHELL, WA--(Marketwire - May 21, 2012) - Marina Biotech, Inc. (OTCQX: MRNA), a leading nucleic acid-based drug discovery and development company, and...
Marina Biotech Receives Three Notices of Allowances From the USPTO and an Intent to Grant Notice From the European Patent Office
May 10, 2012 06:30 ET
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwire - May 10, 2012) - Marina Biotech, Inc. (OTCQX: MRNA), a leading nucleic acid-based drug discovery and development company, today announced that the U.S. Patent and...
Marina Biotech Announces Worldwide Exclusive Licensing Agreement With Monsanto
May 08, 2012 06:30 ET
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwire - May 8, 2012) - Marina Biotech, Inc. (OTCQX: MRNA) announced today that it has entered into an exclusive licensing agreement with Monsanto Company for Marina Biotech's...
Marina Biotech Regains Intellectual Property Rights to Its tkRNAi(TM) Technology for Agriculture and Veterinary Uses
April 19, 2012 06:30 ET
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwire - Apr 19, 2012) - Marina Biotech, Inc. (OTCQX: MRNA), a leading nucleic acid-based drug discovery and development company, today announced that it has regained intellectual...
Marina Biotech Completes Dosing of Second Cohort in the Phase 1b START-FAP Clinical Trial of CEQ508
April 03, 2012 06:30 ET
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwire - Apr 3, 2012) - Marina Biotech, Inc. (OTCQX: MRNA), a leading nucleic acid-based drug discovery and development company, today announced the completion of dosing for Cohort...